Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-599-1 | CAS number: 57158-29-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
"Aluminium":
Absorption rate - oral: 1%
Absorption rate - dermal: 1%
Absorption rate - inhalation: 2%
"Zirconium":
Absorption rate - oral: 1%
Absorption rate - dermal: 1%
Absorption rate - inhalation: 2%
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 1
- Absorption rate - dermal (%):
- 1
- Absorption rate - inhalation (%):
- 2
Additional information
Aluminium
Aluminium is poorly absorbed following either oral or inhalation exposure and is essentially not absorbed dermally. Approximately 0.1–0.6% of ingested aluminium is usually absorbed, although absorption of less bioavailable forms, such as aluminium hydroxide, can be on the order of 0.1%.The main mechanism of absorption is probably passive diffusion through paracellular pathways. Aluminium binds to various ligands in the blood and distributes to every organ, with highest concentrations found in bone and lung tissues. Absorbed aluminium is excreted principally in the urine and, to a lesser extent, in the bile; unabsorbed aluminium is excreted via faeces. Only under certain atypical conditions such as renal dysfunction with concurrent high aluminium intakes, can levels of aluminium in the body rise high enough to cause toxicity in humans; the main target organs under these conditions appear to be the central nervous system and bone (source: ATSDR, 2008).
Oral absorption: based on the above, a conservative default oral absorption of 1% will be assumed for risk assessment purposes.
Dermal absorption of aluminium (test substance: aluminium chlorohydrate) has been shown experimentally to be very low with approx. 0.1-0.2% (Flarend, 2001). In the absence of substance-specific data, the HERAG default value of 1% will be assumed as a conservative assumption for risk assessment purposes.
Inhalation absorption: the percentage of aluminium absorbed following inhalation exposure was not reported in occupational toxicokinetic studies, but a fractional absorption of 1.5–2% was estimated based on the relationship between urinary aluminium excretion and the airborne soluble aluminium to which workers were exposed (Yokel and McNamara 2001, cited in ATSDR, 2008). Given that systemic absorption of airborne aluminium occurs partly via the lungs but also partly via the gastrointestinal tract after mucociliary clearance from the respiratory tract, the above stated value of 2% will be taken forward for risk assessment purposes.
Zirconium
Data on toxicokinetics of zirconium in the public domain are sparse. Nevertheless, the following conclusions are useful for orientating risk assessment purposes:
Oral absorption: in a study with rats, the maximal uptake of various zirconium compounds from the gastrointestinal tract was found to be 0.2 % of the elemental zirconium dose (Fletcher 1969). In another study, the uptake of only 0.001 % of the zirconium dose (ZrCl4) from the gastrointestinal tract into the bloodstream was demonstrated (Clayton and Clayton 1981, cited in MAK, 1999) Based on the above, a conservative default oral absorption of 1% will be assumed for risk assessment purposes.
Dermal absorption: in the absence of substance-specific data, the HERAG default value of 1% will be assumed as a conservative assumption for risk assessment purposes.
Inhalation absorption: data specifically for zirconium absorption form the lungs are not available. However, in view of the similarly low systemic availability of zirconium when compared to aluminium (estimated inhalation absorption 1.5–2%), the reasonable assumption that systemic absorption will occur via lungs and also gastrointestinal tract after mucociliary clearance and any inhalation exposure to “aluminium zirconium chloride hydrate” will intrinsically yield the same deposition pattern in the respiratory tract, the above stated value of 2% is also considered appropriate to be taken forward for risk assessment purposes of zirconium.
References
ATSDR, 2008: Agency for Toxic Substances and Disease Registry (ATSDR). 2008. Toxicological profile for Aluminum. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
Clayton and Clayton, 1981 (Ed.): The metals (Chapter authored by Stockinger, E.). In: Patty's industrial hygiene and toxicology. New York, NY: John Wiley Sons, 1493-1505.
Flarend, 2001: A preliminary study of the dermal absorption of aluminum from antiperspirants using aluminum-26. Food Chem Toxicol 39(2):163-168.
Fletcher,1969: The radiological hazards of zirconium-95 and niobium-95. Health Phys16:209–220
MAK, 1999: Zirconium and its compounds [MAK Value Documentation, 1999]. The MAK Collection for Occupational Health and Safety. 224–236.
HERAG: Health Risk Assessment Guidance for Metals. Fact Sheet 01: Assessment of occupational dermal exposure and dermal absorption for metals and inorganic metal compounds. http://www.icmm.com/page/1213/health-risk-assessment-guidance-for-metals-herag [link accessed 2013-02-05]
Yokel and McNamara, 2001: Aluminium Toxicokinetics: An Updated MiniReview. Pharmacology & Toxicology 2001, 88, 159-167
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.